M. De Miguel

机构：Hospital Universitario HM Sanchinarro

发表论文 7 篇 · 总被引 45 次 · h-index 3

代表论文

• OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation (2022 · Journal of Thoracic Oncology · 被引 22)
• 1257MO ABBV-400, a c-Met protein-targeting antibody-drug conjugate (ADC), in patients (Pts) with advanced EGFR wildtype (WT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase I study (2024 · Annals of Oncology · 被引 12)
• LBA27 First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients (2024 · Annals of Oncology · 被引 8)
• 616MO Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors (2024 · Annals of Oncology · 被引 2)
• Precemtabart tocentecan (Precem-TcT, M9140) in patients with mCRC: Efficacy and safety data at the recommended development dose in the PROCEADE-CRC-01 study. (2026 · Journal of Clinical Oncology · 被引 1)
• P3.18.68 First-In-Human Trial of PFL-241/STX-241 in Patients With Locally Advanced or Metastatic NSCLC Resistant to EGFR Tyrosine Kinase Inhibitors (2025 · Journal of Thoracic Oncology)